NAGK
Basic information
Region (hg38): 2:71064344-71079808
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAGK gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 37 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 38 | 4 | 0 |
Variants in NAGK
This is a list of pathogenic ClinVar variants found in the NAGK region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-71068606-C-G | not specified | Uncertain significance (Jul 06, 2021) | ||
2-71068624-A-G | not specified | Likely benign (Nov 24, 2024) | ||
2-71068657-G-T | not specified | Uncertain significance (Jul 14, 2023) | ||
2-71068688-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
2-71068697-A-G | not specified | Uncertain significance (Dec 14, 2024) | ||
2-71070578-A-G | not specified | Uncertain significance (May 23, 2023) | ||
2-71070817-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
2-71070826-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
2-71071720-C-A | not specified | Uncertain significance (Aug 20, 2024) | ||
2-71071753-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
2-71071762-A-G | not specified | Uncertain significance (Mar 01, 2024) | ||
2-71071791-G-A | not specified | Uncertain significance (Aug 04, 2021) | ||
2-71071797-G-A | not specified | Uncertain significance (May 17, 2023) | ||
2-71071800-G-A | not specified | Uncertain significance (Dec 16, 2024) | ||
2-71071806-A-G | not specified | Uncertain significance (Jun 04, 2024) | ||
2-71071822-C-T | not specified | Uncertain significance (Mar 01, 2025) | ||
2-71072655-A-T | not specified | Uncertain significance (Mar 18, 2024) | ||
2-71072674-A-G | not specified | Uncertain significance (Jan 22, 2025) | ||
2-71072691-C-G | not specified | Uncertain significance (Jul 16, 2021) | ||
2-71072704-A-G | not specified | Uncertain significance (May 25, 2022) | ||
2-71072728-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
2-71072743-A-G | not specified | Uncertain significance (Dec 16, 2022) | ||
2-71073493-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
2-71073533-A-G | not specified | Uncertain significance (Jan 01, 2025) | ||
2-71073539-A-C | not specified | Uncertain significance (Jul 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAGK | protein_coding | protein_coding | ENST00000455662 | 10 | 15462 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.55e-9 | 0.370 | 125689 | 1 | 58 | 125748 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.434 | 241 | 223 | 1.08 | 0.0000127 | 2521 |
Missense in Polyphen | 68 | 64.357 | 1.0566 | 732 | ||
Synonymous | -0.664 | 103 | 94.8 | 1.09 | 0.00000616 | 786 |
Loss of Function | 0.848 | 15 | 19.0 | 0.790 | 9.79e-7 | 206 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000301 | 0.000301 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000273 | 0.000264 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000525 | 0.000523 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Converts endogenous N-acetylglucosamine (GlcNAc), a major component of complex carbohydrates, from lysosomal degradation or nutritional sources into GlcNAc 6-phosphate. Involved in the N-glycolylneuraminic acid (Neu5Gc) degradation pathway: although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded. Also has ManNAc kinase activity. {ECO:0000269|PubMed:22692205}.;
- Pathway
- Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Sialuria or French Type Sialuria;Sialuria or French Type Sialuria;2-Hydroxyglutric Aciduria (D And L Form);Amino Sugar Metabolism;G(M2)-Gangliosidosis: Variant B, Tay-sachs disease;Tay-Sachs Disease;Homocarnosinosis;Hyperinsulinism-Hyperammonemia Syndrome;Succinic semialdehyde dehydrogenase deficiency;4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency;Salla Disease/Infantile Sialic Acid Storage Disease;Glutamate Metabolism;<i>N</i>-acetylglucosamine degradation II;Aminosugars metabolism;Post-translational protein modification;Metabolism of proteins;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.819
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.36
Haploinsufficiency Scores
- pHI
- 0.0834
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.567
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.992
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nagk
- Phenotype
- hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- N-acetylglucosamine metabolic process;UDP-N-acetylglucosamine biosynthetic process;N-acetylmannosamine metabolic process;N-acetylneuraminate catabolic process;carbohydrate phosphorylation
- Cellular component
- cytosol;extracellular exosome
- Molecular function
- protein binding;ATP binding;N-acetylglucosamine kinase activity